Lobbying Filing Details

Total Spending

$200,000

Activities

7

Lobbyists

1

Gov't Entities

63

Filing Information
Filing UUID:
68a4101c-171a-4358-8a60-16d06da29453
Type:
Q4 - 4th Quarter - Report
Period:
2020 - 4th Quarter (Oct 1 - Dec 31)
Date Posted:
January 26, 2021 at 11:19 PM
Income:
$0
Expenses:
$200,000
Expense Method:
Method A - Reporting amounts using LDA definitions only
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Piper Nieters Su
Registrant
MAYO CLINIC

Healthcare provider

Rochester, Minnesota
Client
MAYO CLINIC
Minnesota, United States of America
Lobbying Activities (7)
Activity 1
Health Issues

Telemedicine; Laboratory Medicine payment and oversight, Medical research funding; Quality; Regulatory relief; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 2
Immigration

Changes to the immigration status of foreign doctors, students, and patients

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 3
Medical/Disease Research/Clinical Labs

Reimbursements and lab payments including PAMA and S. 6102, the Verifying Accurate Leading-edge IVCT Development Act of 2020; Regulation of and reimbursements for testing related to COVID-19; Medical research funding; Regulatory relief; Laboratory diagnostic tests; Rural health; Innovation in treatments for COVID-19 including convalescent plasma

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 4
Medicare/Medicaid

Medicare physician payments; Medicare hospital payments; Medicare clinical lab payments; Quality and Transparency; Medicaid Fiscal Accountability Regulation proposal; Clinical laboratory capacity and reimbursements; Federal funding for expenses or lost revenues attributable to COVID-19; H.R. 6074, the Coronavirus preparedness and Response Supplemental Appropriations Act; H.R. 6201, the Families First Coronavirus Response Act; H.R. 748, the Coronavirus Aid, Relief, and Economic Security Act; H.R. 266, the Paycheck Protection Act; H.R. 6800, the HEROES Act; S. 178, the HEALS Act

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 5
Pharmacy

Drug shortages

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 6
Science/Technology

Telemedicine technology; New diagnostic tests, Precision medicine; Broadband expansion and Internet access; Privacy and data security and usage

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more
Activity 7
Veterans

Reimbursement and coverage issues related to VA health care and Tricare

Lobbyists (1)
  • SARAH CURTIS
Government Entities (9)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Executive Office of the President (EOP)
  • White House Office
  • Office of the Vice President of the United States
  • ... and 4 more

Source: LDA.gov, data retrieved November 9, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.